OPTIMIZERx Corporation (OTCBB: OPRX)
announced today that it has moved from the OTC Pink Sheets listing
and is now on the OTC Bulletin Board.
"Being cleared for the OTC Bulletin Board is a big step for
OPTIMIZERx and its investors," said David Lester, CEO of OPTIMIZERx.
"It will provide greater outside investment opportunity into
OPTIMIZERx as we continue to develop and introduce new solutions to
the marketplace."
OPTIMIZERx recently announced the introduction of SampleMD, a new
solution for the distribution and administration of drug sampling
and prescribed therapy persistency program at the Pharmaceutical
Sampling conference in Philadelphia. "The conference validated that
the industry is ready for a new approach at administrating and
distributing branded samples," said David Harrell, Chairman of
OPTIMIZERx and creator of SampleMD. "With fewer physicians no longer
seeing drug reps, along with increasing compliance factors
associated with distributing physical drug samples, pharmaceutical
manufacturers are looking for new channels to the physicians and
health care providers."
To learn more about SampleMD, visit
http://beta.samplemd.com
About OPTIMIZERx
OPTIMIZERx provides unique platforms to help patients better
afford and comply to their medicines and healthcare
products, while offering pharmaceutical and healthcare
companies effective ways to expand patient awareness, access
and adherence to their brands. The Company's patient support
website,
www.OPTIMIZERx.com, and its permanent subscriber base,
continue to grow each month and is quickly becoming the
preferred way to access branded prescription savings and
support programs.
Additionally, OPTIMIZERx has
developed OFFERx(TM) and ADHERxE(TM) to allow a more
streamlined, effective way to create, promote and manage new
trial or co-pay programs on behalf of brand-name
pharmaceuticals and health care products.
Visit us online:
www.optimizerx.com
Yahoo Finance:
OPTIMIZERx Profile
